Can an ultrasound predict who can skip surgery for rectal cancer?

NCT ID NCT03068403

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special ultrasound technique (D-CEUS) can predict how well rectal cancer responds to chemotherapy and radiation. The goal is to identify good responders who might avoid major surgery and instead have a less invasive procedure. Only 2 people took part, making this a very early exploration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dynamic contrast-enhanced ultrasound (D-CEUS) with Sonovue contrast agent

What this could lead to

If successful, this imaging method could help identify rectal cancer patients who respond well to chemoradiation, allowing them to avoid major surgery.

What could go wrong

This was a very small early study with only 2 participants, so results may not apply to larger groups. The technique is still experimental and needs much more testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal carcinoma rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, France